New Clinical Insights into Chronic Obstructive Pulmonary Disease and Their Implications for Pharmacoeconomic Analyses

Chronic obstructive pulmonary disease (COPD) is one of the leading causes of death and disability worldwide, but before the development of several new pharmacological treatments little could be done for COPD patients. Recognition that these new treatments could significantly improve the prognosis fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Mapel, Douglas W., Roberts, Melissa H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2012
Materias:
Practical Application
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3625413/
https://www.ncbi.nlm.nih.gov/pubmed/22852587
http://dx.doi.org/10.2165/11633330-000000000-00000

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3625413/
https://www.ncbi.nlm.nih.gov/pubmed/22852587
http://dx.doi.org/10.2165/11633330-000000000-00000

Ejemplares similares